María Lomas
34 works · 718 citations · h-index 9
Top works
- Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
- Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)
- Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study
- Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer
- Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer
- Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study
- Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer
- Gemcitabine/Vinorelbine in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines: Results of a Phase II Trial
- A combination of oxaliplatin and UFT-l,-leucovorin as first line treatment in advanced colorectal cancer. An ONCOPAZ phase II study
- Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes
- Functions and workload of medical oncologists in Spain
- Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital
- Prognostic factors for relapse in stage I seminoma managed by surveillance or adjuvant carboplatin: A multivariate analysis on 588 cases
- 40 Prospective randomized trial of high-dose epirubicin-cisplatin (EP) vs etoposide-cisplatin (VP) in small cell lung cancer (SCLC)
- 27 Gemcitabine plus cisplatin versus etoposide plus cisplatin in advanced non-small cell lung cancer: A randomized trial by the Spanish lung cancer group
- Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response
- The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer
- 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience
- Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
- Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas